General Information of Drug Formulation (ID: F24435)

Formulation Name
Amlodipine Besylate eq 2.5mg base capsule
Company
Novartis
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Amlodipine DMBDAZV Angina pectoris BA40 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Calcium phosphate E00298 24456 Anticaking agent; Buffering agent; Desiccant; Diluent
Cellulose microcrystalline E00698 Not Available Adsorbent; Suspending agent; Diluent
Crospovidone E00626 Not Available Disintegrant
Ferrosoferric oxide E00231 14789 Colorant
Gelatin E00630 Not Available Other agent
Hydrophobic colloidal silica E00285 24261 Anticaking agent; Emulsion stabilizing agent; Glidant; Suspending agent; Viscosity-controlling agent
Lactose monohydrate E00393 104938 Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate E00208 11177 lubricant
Polysorbate 80 E00665 Not Available Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Silicon dioxide E00670 Not Available Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate E00464 3423265 Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Talc E00520 16211421 Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent
Trihydroxystearin E00317 25100 Emollient; Emulsifying agent; Solvent; Surfactant; Viscosity-controlling agent